• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇的多效性作用。

Pleiotropic effects of resveratrol.

作者信息

Granados-Soto Vinicio

机构信息

Laboratorio de Farmacologia, Instituto de Investigaciones Quimico-Biologicas, Universidad Michoacana de San Nicolas de Hidalgo, Morelia, Michoacan, Mexico.

出版信息

Drug News Perspect. 2003 Jun;16(5):299-307. doi: 10.1358/dnp.2003.16.5.829318.

DOI:10.1358/dnp.2003.16.5.829318
PMID:12942161
Abstract

Resveratrol, a phytoalexin found in red wine, has several pharmacological properties which include inhibition of arachidonate metabolism in leukocytes and platelets, modulation of lipid metabolism, inhibition of platelet aggregation and lipid peroxidation, reduction of expression and activity of cyclooxygenase-2. Resveratrol induces cell cycle arrest at S/G(2) phase transition and a pro-apoptotic cell death in several types of cancer cells. All these biological activities help to explain the vasorelaxing, anticancer and antiinflammatory activity of resveratrol. This article summarizes the wide range of biological activities of resveratrol in three disease states: cancer, coronary heart disease and pain. In addition, the mechanisms underlying these promising properties of resveratrol are also reviewed.

摘要

白藜芦醇是一种存在于红酒中的植物抗毒素,具有多种药理特性,包括抑制白细胞和血小板中的花生四烯酸代谢、调节脂质代谢、抑制血小板聚集和脂质过氧化、降低环氧合酶-2的表达和活性。白藜芦醇可诱导多种癌细胞在S/G(2)期转变时发生细胞周期停滞并导致促凋亡细胞死亡。所有这些生物学活性有助于解释白藜芦醇的血管舒张、抗癌和抗炎活性。本文总结了白藜芦醇在癌症、冠心病和疼痛这三种疾病状态下的广泛生物学活性。此外,还对白藜芦醇这些有前景特性的潜在机制进行了综述。

相似文献

1
Pleiotropic effects of resveratrol.白藜芦醇的多效性作用。
Drug News Perspect. 2003 Jun;16(5):299-307. doi: 10.1358/dnp.2003.16.5.829318.
2
Resveratrol inhibits the expression of cyclooxygenase-2 in mammary epithelial cells.白藜芦醇抑制乳腺上皮细胞中环氧化酶 -2 的表达。
Adv Exp Med Biol. 2001;492:147-57. doi: 10.1007/978-1-4615-1283-7_12.
3
Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures.从葡萄(欧亚葡萄)细胞培养物中提取的葡萄酒芪类化合物和黄烷类化合物的潜在癌症化学预防活性。
Nutr Cancer. 2001;40(2):173-9. doi: 10.1207/S15327914NC402_14.
4
Herbal medicine, cancer prevention and cyclooxygenase 2 inhibition.草药、癌症预防与环氧化酶2抑制作用
Trends Pharmacol Sci. 2003 May;24(5):218-9. doi: 10.1016/S0165-6147(03)00070-1.
5
Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells.白藜芦醇抑制人乳腺上皮细胞中环氧化酶 -2 的转录。
Ann N Y Acad Sci. 1999;889:214-23. doi: 10.1111/j.1749-6632.1999.tb08737.x.
6
Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.经典非甾体抗炎药以及选择性环氧化酶(COX)-1和COX-2抑制剂在慢性胃溃疡愈合中的作用
Microsc Res Tech. 2001 Jun 1;53(5):343-53. doi: 10.1002/jemt.1102.
7
Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw.白藜芦醇可减轻角叉菜胶诱导的大鼠后爪痛觉过敏。
Life Sci. 2001 Feb 2;68(11):1317-21. doi: 10.1016/s0024-3205(00)01018-3.
8
Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: a structure-activity relationship study.红酒间苯二酚对COX-1的基于机制的失活:构效关系研究
J Nat Prod. 2004 Nov;67(11):1777-82. doi: 10.1021/np0498410.
9
Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness.环氧化酶-1和环氧化酶-2均介导成骨细胞对钛表面粗糙度的反应。
J Biomed Mater Res. 2001 Jun 5;55(3):350-9. doi: 10.1002/1097-4636(20010605)55:3<350::aid-jbm1023>3.0.co;2-m.
10
Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.环氧化酶衍生的前列腺素E2和一氧化氮在低剂量脂多糖对大鼠胰腺的保护作用中的参与。
J Physiol Pharmacol. 2001 Mar;52(1):107-26.

引用本文的文献

1
Perspective on the Coevolutionary Role of Host and Gut Microbiota in Polyphenol Health Effects: Metabotypes and Precision Health.多酚健康效应中宿主与肠道微生物群共进化作用的研究视角:代谢类型与精准健康
Mol Nutr Food Res. 2024 Nov;68(22):e2400526. doi: 10.1002/mnfr.202400526. Epub 2024 Nov 13.
2
Resveratrol: A potential therapeutic natural polyphenol for neurodegenerative diseases associated with mitochondrial dysfunction.白藜芦醇:一种针对与线粒体功能障碍相关的神经退行性疾病的潜在治疗性天然多酚。
Front Pharmacol. 2022 Sep 16;13:922232. doi: 10.3389/fphar.2022.922232. eCollection 2022.
3
Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.
帕金森病中的神经炎症及其治疗机会。
Balkan Med J. 2022 Sep 9;39(5):318-333. doi: 10.4274/balkanmedj.galenos.2022.2022-7-100. Epub 2022 Aug 29.
4
Protective effect of resveratrol against neuronal damage through oxidative stress in cerebral hemisphere of aluminum and fluoride treated rats.白藜芦醇对铝和氟处理大鼠大脑半球氧化应激所致神经元损伤的保护作用
Interdiscip Toxicol. 2016 Jun;9(2):78-82. doi: 10.1515/intox-2016-0009. Epub 2017 May 17.
5
Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects.糖尿病并发症中的辅助佐剂:具有多效性的营养保健品和药物。
Int J Mol Sci. 2016 Aug 5;17(8):1273. doi: 10.3390/ijms17081273.
6
Resveratrol inhibits Cdk5 activity through regulation of p35 expression.白藜芦醇通过调节 p35 的表达抑制 Cdk5 的活性。
Mol Pain. 2011 Jul 7;7:49. doi: 10.1186/1744-8069-7-49.
7
Acetylation and nuclear receptor action.乙酰化和核受体作用。
J Steroid Biochem Mol Biol. 2011 Feb;123(3-5):91-100. doi: 10.1016/j.jsbmb.2010.12.003. Epub 2010 Dec 15.
8
Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects.每日两次与食物、槲皮素和酒精(乙醇)同服 2000 毫克反式白藜芦醇在健康人体的药代动力学和耐受性的稳态研究。
Clin Pharmacokinet. 2010 Jul;49(7):449-54. doi: 10.2165/11531820-000000000-00000.
9
Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease.在亨廷顿舞蹈症果蝇模型中,抑制特定的组蛋白去乙酰化酶(HDACs)和沉默调节蛋白可抑制疾病进展。
Hum Mol Genet. 2008 Dec 1;17(23):3767-75. doi: 10.1093/hmg/ddn273. Epub 2008 Sep 1.
10
Resveratrol: a natural compound with pharmacological potential in neurodegenerative diseases.白藜芦醇:一种在神经退行性疾病中具有药理学潜力的天然化合物。
CNS Neurosci Ther. 2008 Fall;14(3):234-47. doi: 10.1111/j.1755-5949.2008.00045.x. Epub 2008 Jul 29.